• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过去二十年心力衰竭死亡模式的趋势:猝死减少,但癌症死亡上升。

Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise.

机构信息

Heart Failure Clinic and Cardiology Service, University Hospital Germans Trias i Pujol, Badalona, Spain.

Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.

出版信息

Eur J Heart Fail. 2019 Oct;21(10):1259-1266. doi: 10.1002/ejhf.1569. Epub 2019 Jul 30.

DOI:10.1002/ejhf.1569
PMID:31359563
Abstract

AIMS

Better management of heart failure (HF) over the past two decades has improved survival, mainly by reducing the incidence of death due to cardiovascular (CV) causes. Deaths due to non-CV causes, particularly cancer, may be increasing. This study explored the modes of death of consecutive patients who attended a HF clinic over 17 years.

METHODS AND RESULTS

A total of 935 deaths were ascertained from 2002 to 2018 among 1876 patients (mean age 65.8 ± 12.5 years, 75% men, left ventricular ejection fraction < 50%) admitted to our HF clinic. Median follow-up was 4.2 years [1.9-7.8]. Mode of death was curated from patient health records and verified by the Catalan and Spanish health system databases. Trends for every mode of death were assessed by polynomial regression. Two trends were observed: a significant reduction in sudden death (P = 0.03) without changes in HF progression as mode of death (P = 0.26), and a significant increase in non-CV modes of death (P < 0.001). Non-CV deaths accounted for 17.4% of deaths in 2002 and 65.8% of deaths in 2018. A total 138 deaths were due to cancer (37% of non-CV deaths). A significant trend was observed towards a progressive increase in cancer deaths over time (P = 0.002). The main mode of cancer mortality was lung cancer.

CONCLUSIONS

The modes of death in HF have shifted over the last two decades. Patients with HF die less due to sudden death and more due to non-CV causes, mainly cancer. Whether HF triggers cancer, or cancer develops in HF survivors, deserves further insight.

摘要

目的

过去二十年来,心力衰竭(HF)管理水平的提高改善了患者的生存率,主要是通过降低心血管(CV)原因导致的死亡率。而非 CV 原因(尤其是癌症)导致的死亡可能在增加。本研究旨在探讨在 17 年时间里连续就诊于 HF 门诊的患者的死亡模式。

方法和结果

共从 2002 年至 2018 年期间在我们 HF 门诊就诊的 1876 例患者(平均年龄 65.8±12.5 岁,75%为男性,左心室射血分数<50%)中确定了 935 例死亡病例。中位随访时间为 4.2 年(1.9-7.8)。死亡模式是从患者的健康记录中提取出来的,并通过加泰罗尼亚和西班牙卫生系统数据库进行了验证。通过多项式回归评估了每种死亡模式的趋势。观察到两种趋势:猝死明显减少(P=0.03),但心力衰竭进展作为死亡模式没有变化(P=0.26),而非 CV 死亡模式显著增加(P<0.001)。非 CV 死亡在 2002 年占死亡人数的 17.4%,而在 2018 年占 65.8%。共有 138 例死亡归因于癌症(非 CV 死亡的 37%)。随着时间的推移,癌症死亡人数呈显著增加趋势(P=0.002)。癌症死亡的主要模式是肺癌。

结论

在过去的二十年中,HF 的死亡模式发生了变化。HF 患者死于猝死的比例降低,死于非 CV 原因(主要是癌症)的比例增加。HF 是否会引发癌症,或者癌症是否在 HF 幸存者中发展,这值得进一步深入研究。

相似文献

1
Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise.过去二十年心力衰竭死亡模式的趋势:猝死减少,但癌症死亡上升。
Eur J Heart Fail. 2019 Oct;21(10):1259-1266. doi: 10.1002/ejhf.1569. Epub 2019 Jul 30.
2
Modes of death in heart failure according to age, sex and left ventricular ejection fraction.心力衰竭患者的死亡模式按年龄、性别和左心室射血分数划分。
Intern Emerg Med. 2021 Apr;16(3):643-652. doi: 10.1007/s11739-020-02468-z. Epub 2020 Aug 19.
3
Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.射血分数保留的心力衰竭伴发心原性猝死:难以捉摸的靶点。
Heart Fail Rev. 2019 Nov;24(6):847-866. doi: 10.1007/s10741-019-09804-2.
4
Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.射血分数降低的心力衰竭的恢复和结局:一项前瞻性研究。
Eur J Heart Fail. 2017 Dec;19(12):1615-1623. doi: 10.1002/ejhf.824. Epub 2017 Apr 6.
5
Trends in Place of Death for Cardiovascular Mortality Related to Heart Failure in the United States From 2003 to 2017.2003 年至 2017 年美国与心力衰竭相关心血管死亡率的死亡地点趋势。
Circ Heart Fail. 2020 Feb;13(2):e006587. doi: 10.1161/CIRCHEARTFAILURE.119.006587. Epub 2020 Feb 14.
6
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.左心室射血分数与心力衰竭或左心室功能障碍并发心肌梗死后的死亡率之间的关系。
Int J Cardiol. 2018 Dec 1;272:260-266. doi: 10.1016/j.ijcard.2018.07.137. Epub 2018 Jul 29.
7
Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients.心力衰竭且射血分数降低与保留患者的死亡模式:住院心力衰竭患者登记报告。
Circ J. 2012;76(7):1662-9. doi: 10.1253/circj.cj-11-1355. Epub 2012 Apr 6.
8
Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.因心力衰竭恶化且左心室射血分数降低而住院的患者的死亡原因和再住院情况:托伐普坦治疗心力衰竭的疗效和生存研究(EVEREST)项目结果。
Am Heart J. 2010 May;159(5):841-849.e1. doi: 10.1016/j.ahj.2010.02.023.
9
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study.瑞马唑仑对急性心力衰竭患者死亡方式的影响:RELAX-AHF 研究结果。
J Am Coll Cardiol. 2014 Oct 14;64(15):1591-8. doi: 10.1016/j.jacc.2014.05.071.
10
Can the mode of death be predicted in patients with angiographically documented coronary artery disease?血管造影证实患有冠状动脉疾病的患者的死亡方式能够被预测吗?
Clin Cardiol. 1983 Aug;6(8):384-95. doi: 10.1002/clc.4960060805.

引用本文的文献

1
Breast cancer surgery under mechanical circulatory support in a patient with cancer therapy-related cardiac dysfunction: a case report.癌症治疗相关心脏功能障碍患者在机械循环支持下进行乳腺癌手术:一例报告
Eur Heart J Case Rep. 2025 Aug 23;9(9):ytaf407. doi: 10.1093/ehjcr/ytaf407. eCollection 2025 Sep.
2
Cardio-Oncology Challenges in Elderly Patients.老年患者的心脏肿瘤学挑战
J Clin Med. 2025 May 7;14(9):3257. doi: 10.3390/jcm14093257.
3
Identification of signature genes and subtypes for heart failure diagnosis based on machine learning.
基于机器学习的心力衰竭诊断特征基因和亚型的识别
Front Cardiovasc Med. 2025 Apr 14;12:1492192. doi: 10.3389/fcvm.2025.1492192. eCollection 2025.
4
Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document.射血分数降低的心力衰竭中的心脏节律装置——当代实践中的作用、时机及最佳应用。欧洲心力衰竭杂志专家共识文件
Eur J Heart Fail. 2025 Jul;27(7):1242-1261. doi: 10.1002/ejhf.3641. Epub 2025 Apr 9.
5
Myocardial Revascularization in Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭患者的心肌血运重建
Dtsch Arztebl Int. 2025 Feb 21;122(4):103-108. doi: 10.3238/arztebl.m2024.0249.
6
Clinical evaluation and outcome in heart failure patients receiving chemotherapy with different anti-cancer agents.接受不同抗癌药物化疗的心力衰竭患者的临床评估及预后
ESC Heart Fail. 2025 Jun;12(3):1965-1976. doi: 10.1002/ehf2.15204. Epub 2025 Jan 13.
7
Cancer and Heart Failure: Dangerous Liaisons.癌症与心力衰竭:危险关联
J Cardiovasc Dev Dis. 2024 Aug 27;11(9):263. doi: 10.3390/jcdd11090263.
8
Cardiovascular Diseases Increase Cancer Mortality in Adults: NHANES-Continuous Study.心血管疾病增加成年人癌症死亡率:NHANES-连续研究。
J Am Heart Assoc. 2024 Aug 6;13(15):e035500. doi: 10.1161/JAHA.124.035500. Epub 2024 Jul 26.
9
Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.来自梗死和衰竭心脏的小细胞外囊泡加速肿瘤生长。
Circulation. 2024 May 28;149(22):1729-1748. doi: 10.1161/CIRCULATIONAHA.123.066911. Epub 2024 Mar 15.
10
Association of CirAEs and Efficacy in NSCLC Patients Treated with PD-1/PD-L1: A Meta-analysis of Cohort Studies.非小细胞肺癌患者接受PD-1/PD-L1治疗时循环不良事件与疗效的关联:队列研究的Meta分析
Comb Chem High Throughput Screen. 2025;28(3):435-446. doi: 10.2174/0113862073267261231106093845.